Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics Group announced today that it is planning a $3.6 million public offering of common stock.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.